How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1829 participants.
Also called NCT01519518
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,829 participants
- Registry
-
NCT01519518
-
- Other papers using this trial's data
- Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01519518. Randomized; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2013-12 (actual). Results posted on 2015-04-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
- Acronym
- HEAT-PPCI
- Condition
- Acute ST Elevation Myocardial Infarction
- Intervention (Drug)
- unfractionated heparin
- Intervention (Drug)
- Bivalirudin
- Lead sponsor
- Liverpool Heart and Chest Hospital NHS Foundation Trust
Record details
- Record id
cardio:ct-nct01519518- Content hash
bf836dd127ac839029d736fc315a88ca0a3e77c1a9de201ee7bdba16b3b51c81